These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33407317)

  • 1. Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.
    Eller P; Flick H; Schilcher G; Moazedi-Fürst F; Eller K; Talakic E; Hermann J; Allanore Y; Olschewski H
    BMC Pulm Med; 2021 Jan; 21(1):13. PubMed ID: 33407317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.
    Rüegg CA; Maurer B; Laube I; Scholtze D
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
    Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
    Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
    Mecoli CA; Christopher-Stine L
    Curr Rheumatol Rep; 2018 Apr; 20(5):27. PubMed ID: 29637383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis.
    Trăilă D; Mlădinescu OF; Oancea C; Tudorache V
    Pneumologia; 2015; 64(2):37-40. PubMed ID: 26506673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanic's hands in a woman with undifferentiated connective tissue disease and interstitial lung disease--anti-PL7 positive antisynthetase syndrome: a case report.
    De Langhe E; Lenaerts J; Bossuyt X; Westhovens R; Wuyts WA
    J Med Case Rep; 2015 Apr; 9():82. PubMed ID: 25888844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical heterogeneity and outcomes of antisynthetase syndrome.
    Hervier B; Benveniste O
    Curr Rheumatol Rep; 2013 Aug; 15(8):349. PubMed ID: 23794106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antisynthetase syndrome: a retrospective study of 14 patients].
    Dieval C; Ribeiro E; Mercié P; Blanco P; Duffau P; Longy-Boursier M
    Rev Med Interne; 2012 Feb; 33(2):76-9. PubMed ID: 22204922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome.
    Pecher AC; Hensen L; Klein R; Schairer R; Lutz K; Atar D; Seitz C; Stanger A; Schneider J; Braun C; Schmidt M; Horger M; Bornemann A; Faul C; Bethge W; Henes J; Lengerke C
    JAMA; 2023 Jun; 329(24):2154-2162. PubMed ID: 37367976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data.
    Robles-Perez A; Dorca J; Castellví I; Nolla JM; Molina-Molina M; Narváez J
    Rheumatol Int; 2020 May; 40(5):719-726. PubMed ID: 32157369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE.
    Deng L; Chen Y; Hu X; Zhou J; Zhang Y
    Front Immunol; 2021; 12():708463. PubMed ID: 34671344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.
    Marie I; Dominique S; Janvresse A; Levesque H; Menard JF
    Respir Med; 2012 Apr; 106(4):581-7. PubMed ID: 22280877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
    Bozkirli DE; Kozanoglu I; Bozkirli E; Yucel E
    J Clin Apher; 2013 Dec; 28(6):422-5. PubMed ID: 23908096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
    Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffuse infiltrating lung disease secondary to antisynthetase syndrome: a case report].
    Moussa N; Khemakhem R; Snoussi M; Fekih W; Bahloul Z; Kammoun S
    Pan Afr Med J; 2021; 39():30. PubMed ID: 34394821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A; Gillissen A; Seidel W
    Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
    Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.